Using patent analysis to explore corporate growth

Scientometrics

Volumn 88, Issue 2, 2011, Pages 433-448

  Chen, Yu Shan ^a  

^a NATIONAL TAIPEI UNIVERSITY   (Taiwan)

Author keywords

Corporate growth; Patent analysis; Patent share (PS); Relative patent position (RPP); Revealed technology advantage (RTA)

Indexed keywords

EID: 79959681739     PISSN: 01389130     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11192-011-0396-8     Document Type: Article

References (47)

1. Barney, J. (1991). Firm resources and sustained competitive advantage. Journal of Management, 17(1), 99-120.
2. Barney, J., & Hesterly, W. (2009). Strategic management and competitive advantage: Concepts and cases. Upper Saddle River, NJ: Prentice Hall Publisher.
3. Branch, B. (1973). Research and development and its relation to sales growth. Journal of Economics and Business, 25(2), 107-111.
4. Breitzman, A., & Thomas, P. (2002). Using patent citation analysis to target/value M& A candidates. Research Technology Management, 45(5), 28-36.
5. Brockhoff, K. (1991). Competitor technology intelligence in German companies. Industrial Marketing Management, 20, 91-98.
6. Cardinal, L. B., & Hatfield, D. E. (2000). Internal knowledge generation: The research laboratory and innovative productivity in the pharmaceutical industry. Journal of Engineering & Technology Management, 17, 247-271.
7. Chen, Y.-S., & Chang, K.-C. (2009). Using neural network to analyze the influence of the patent performance upon the market value of the US pharmaceutical companies. Scientometrics, 80(3), 637-655.
8. Chen, Y.-S., & Chang, K.-C. (2010a). The relationship between a firm's patent quality and its market value-the case of US pharmaceutical industry. Technological Forecasting and Social Change, 77(1), 20-33.
9. Chen, Y.-S., & Chang, K.-C. (2010b). Exploring the nonlinear effects of patent citations, patent share, and relative patent position on market value in the US pharmaceutical industry. Technology Analysis & Strategic Management, 22(2), 153-169.
10. Chen, Y.-S., & Chang, K.-C. (2010c). The nonlinear nature of the relationships between the patent traits and corporate performance. Scientometrics, 82(1), 201-210.
11. Chen, Y.-S., & Chang, K.-C. (2010d). Analyzing the nonlinear effects of firm size, profitability, and employee productivity on patent citations of the US pharmaceutical companies by using artificial neural network. Scientometrics, 82(1), 75-82.
12. Chen, Y.-S., Lin, M.-J. J., & Chang, C.-H. (2006). The influence of intellectual capital on new product development performance-the manufacturing companies of Taiwan as an example. Total Quality Management and Business Excellence, 17(10), 1323-1339.
13. Deng, Z., Lev, B., & Narin, F. (1999). Science and technology as predictors of stock performance. Financial Analysts Journal, 55, 20-32.
14. Ernst, H. (1995). Patenting strategies in the German mechanical engineering industry and their relationship to company performance. Technovation, 15(4), 225-240.
15. Ernst, H. (1998). Patent portfolios for strategic R& D planning. Journal of Engineering and Technology Management, 15, 279-308.
16. Ernst, H. (1999). Evaluation of dynamic technological developments by means of patent data. In K. Brockhoff, A. K. Chakrabarti, & J. Hauschildt (Eds.), The dynamics of innovation: Strategic and managerial implications. Berlin: Springer Corp.
17. Ernst, H. (2001). Patent applications and subsequent changes of performance: Evidence from time-series cross-section analyses on the firm level. Research Policy, 30, 143-157.
18. Ernst, H. (2003). Patent information for strategic technology management. World Patent Information, 25, 233-242.
19. Feeny, S., & Rogers, M. (2003). Innovation and performance: Benchmarking Australian firms. Australian Economic Review, 36(3), 253-264.
20. Gebhart, F. (2006). Major drugs lose patent protection in 2006. Drug Topics Supplements, 150, 8-10.
21. Grabowski, H., & Vernon, J. (1990). A new look at the returns and risks to pharmaceutical R& D. Management Science, 36, 804-821.
22. Granstrand, O., Patel, P., & Pavitt, K. (1997). Multitechnology corporations: Why they have distributed rather than distinctive core competencies. California Management Review, 39(4), 8-25.
23. Greene, W. H. (2003). Econometric analysis. Upper Saddle River, NJ: Prentice-Hall Publisher.
24. Hall, B. H., Jaffe, A., & Trajtenberg, M. (2005). Market value and patent citations. Rand Journal of Economics, 36(1), 16-38.
25. Henry, G. (2002). Patents, innovation, and access to new pharmaceuticals. Journal of International Economic Law, 5(4), 849-860.
26. Hoy, F., McDougall, P. P., & Dsouza, D. E. (1992). Strategies and environments of high growth firms. In D. L. Sexton & J. D. Kasarda (Eds.), The state of the art of entrepreneurship. Boston: PWS-Kent Publishing.
27. Hsiao, C. (1986). Analysis of panel data. Cambridge, UK: Cambridge University Press.
28. IMS Health. (2010). Global pharmaceutical market growth of 5-7 percent in 2011. Norwalk, CT: IMS Health.
29. Jensen, E. (1987). Research expenditures and the discovery of new drugs. Journal of Industrial Economics, 36, 83-95.
30. Johnson, W. H. A. (1999). An integrative taxonomy of intellectual capital: Measuring the stock and flow of intellectual capital components in the firm. International Journal of Technology Management, 18(5-8), 562-575.
31. Lee, Y. G., Lee, J. D., Song, Y. I., & Lee, S. J. (2007). An in-depth empirical analysis of patent citation counts using zero-inflated count data model: The case of KIST. Scientometrics, 70(1), 27-39.
32. Levin, R. C., Klevorick, A. K., Nelson, R. R., & Winter, S. G. (1987). Appropriating the returns from industrial research and development. Bookings Paper on Economic Activity, 3, 783-820.
33. Lin, B., & Chen, J. (2005). Corporate technology portfolios and R& D performance measures: A study of technology intensive firms. R& D Management, 35(2), 157-170.
34. Maddala, G. S. (1993). The econometrics of panel data. Aldershot: Elgar Publisher.
35. Mansfield, E. (1986). Patents and innovation: An empirical study. Management Science, 32, 173-181.
36. Miller, S. M. (1990). The strategic management of technological R& D: An ideal process for the 1990s. International Journal of Technology Management, 5(2), 153-163.
37. Patel, P., & Pavitt, K. (1997). The technological competency of the world's largest firms: Complex path-dependent, but not much variety. Research Policy, 26, 141-156.
38. Pearson, A. E. (2002). Tough-minded ways to get innovative. Harvard Business Review, 80(8), 117-125.
39. Prahalad, C. K., & Hamel, G. (1990). The core competence of the corporation. Harvard Business Review, 68, 79-91.
40. Rosenberg, J. B. (1976). Research and market share: A reappraisal of the Schumpeter hypothesis. Journal of Industrial Economics, 25(2), 101-111.
41. Scherer, F. M. (1965). Corporate inventive output, profits, and growth. Journal of Political Economy, 73(3), 190-197.
42. Schmookler, J. (1966). Invention and economic growth. Boston: Harvard University Press.
43. Soete, L., & Wyatt, S. (1983). The use of foreign patenting as an internationally comparable science and technology output indicator. Scientometrics, 5(1), 31-54.
44. Teece, D. J. (1986). Profiting from technological innovation: Implications for integration, collaboration, licensing and public policy. Research Policy, 15(6), 285-305.
45. Urabe, K. (1988). Innovation and management: International comparisons. New York: Walter de Gruyter & Co.
46. U. S. Bureau of Economic Analysis. (2010). Industry economic accounts. Washington, DC: U. S. Bureau of Economic Analysis.
47. Zahra, S. A., & Bogner, W. C. (1999). Technology strategy and software new ventures' performance: Exploring the moderating effect of the competitive environment. Journal of Business Venturing, 15(2), 135-173.